NCT05320380 2023-09-01A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatChildren's Oncology GroupPhase 1/2 Withdrawn
NCT01804101 2018-05-25Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid LeukemiaFred Hutchinson Cancer CenterPhase NA Completed48 enrolled 9 charts